Skip to main content
OpenTrials

Clinical trial condition

Urologic Neoplasms

Explore clinical trials studying Urologic Neoplasms. Study availability and eligibility vary by location and protocol.

2,957 public trials 633 recruiting studies
Refine in advanced search Browse all conditions

Urologic Neoplasms trial results

Completed

Atrasentan in Treating Patients With Locally Recurrent or Metastatic Kidney Cancer

NCT00039429

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations
  • Mayo Clinic Scottsdale Scottsdale, Arizona, United States
  • Aurora Presbyterian Hospital Aurora, Colorado, United States
  • Boulder Community Hospital Boulder, Colorado, United States
  • Penrose Cancer Center at Penrose Hospital Colorado Springs, Colorado, United States
View all 177 locations
View Trial Details
Completed

A Study of the PD-L1xCD27 Bispecific Antibody CDX-527 in Patients With Advanced Malignancies

NCT04440943

Conditions
Adenocarcinoma, Adnexal Diseases, Bladder Urothelial Carcinoma, +61 more
Locations
  • Northside Hospital Atlanta, Georgia, United States
  • University of Chicago Chicago, Illinois, United States
  • Oncology Hematology West, PC dba Nebraska Cancer Specialists Omaha, Nebraska, United States
  • Duke Cancer Center Durham, North Carolina, United States
View Trial Details
Completed

Docetaxel and Gemcitabine in Treating Patients With Progressive Regional or Metastatic Bladder Cancer

NCT00004223

Conditions
Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
Locations
  • CCOP - Scottsdale Oncology Program Scottsdale, Arizona, United States
  • Cancer Center and Beckman Research Institute, City of Hope Duarte, California, United States
  • Veterans Affairs Medical Center - Palo Alto Palo Alto, California, United States
  • Stanford University Medical Center Stanford, California, United States
View all 76 locations
View Trial Details
Completed

Paclitaxel and Carboplatin in Treating Patients With Locally Advanced or Metastatic Renal Cell Cancer

NCT00077129

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations
  • Baptist Cancer Institute - Jacksonville Jacksonville, Florida, United States
  • Rush-Copley Cancer Care Center Aurora, Illinois, United States
  • Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago, Illinois, United States
  • Hematology and Oncology Associates Chicago, Illinois, United States
View all 35 locations
View Trial Details
Completed

Combination Chemotherapy in Treating Patients With Bladder Cancer

NCT00003701

Conditions
Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +12 more
Locations
  • Veterans Affairs Medical Center - Atlanta (Decatur) Decatur, Georgia, United States
  • Indiana University Hospitals Indianapolis, Indiana, United States
  • Hunterdon Regional Cancer Center Flemington, New Jersey, United States
  • Hackensack University Medical Center Hackensack, New Jersey, United States
View all 13 locations
View Trial Details
Completed

Sunitinib Malate With or Without Gemcitabine Hydrochloride in Treating Patients With Advanced Kidney Cancer That Cannot Be Removed By Surgery

NCT01164228

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations
  • UAB Comprehensive Cancer Center Birmingham, Alabama, United States
  • Mayo Clinic Scottsdale Scottsdale, Arizona, United States
  • Stanford Cancer Center Stanford, California, United States
  • Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center Hartford, Connecticut, United States
View all 99 locations
View Trial Details
Completed

Mind-Body Health in Uro-Oncology: Research Study

NCT03852030

Conditions
Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +18 more
Locations
  • Northwestern University Chicago, Illinois, United States
  • NorthShore University HealthSystem Evanston, Illinois, United States
View Trial Details

Related conditions